Home

Results 1 - 10 of 194,349 for treatment. Search took 0.498 seconds.  
Sort by date/Sort by relevance
WHO | WHO awards million dollar contract for global treatment preparedness activities Access Home Alt+0 Content Alt+2 Search Menu 3 by 5 home About 3 by 5 Country support Capacity building Partnership AIDS medicines and diagnostics service Documents Media centre WHO awards million dollar contract for global treatment preparedness activities WHO/Sven Torfinn 18 NOVEMBER 2004 | GENEVA -- The World Health Organization (WHO) is awarding a USD$1 million contract to a global consortium of people living with HIV/AIDS and treatment activists to help prepare people living with HIV/AIDS (PLWHA) for antiretroviral treatment (ART). (...) The WHO initiative supports community-based treatment preparedness activities as part of the drive to increase access to treatment and prevention in line with the "3 by 5" target to get three million people living with AIDS on antiretroviral treatment by the end of 2005. (...) Those who currently have access to treatment need this knowledge to be informed about their treatment and to ensure they know how and when to take their medicines.
Language:English
Score: 652490.4 - https://www.who.int/3by5/mediacentre/news31/en/
Data Source: un
Microsoft Word - Ch 10 text only.doc Treatment Monitoring The Gypsy Moth Treatment Monitoring Program establishes the procedures and standards necessary for evaluating suppression projects. (...) At a minimum, the evaluation should include 30% of the total number of blocks treated representing at least 50% of the project area (hectares). Treatment Monitoring procedures require four stages of data collection: - pre-treatment - aircraft calibration - on-site monitoring (during treatment) - post-treatment Data collected during all four stages is necessary for a spray block to be entered into the Treatment Monitoring Program. (...) If treatment occurs on more than one day, record treatment block data for subsequent days’ treatment.
Language:English
Score: 651448.4 - https://www.fao.org/forestry/6...7d1c04314b4b5c324789bd26eb.pdf
Data Source: un
Microsoft Word - TMDB MANUAL.DOC 1 What is the Gypsy Moth Treatment Monitoring Program? The Gypsy Moth Treatment Monitoring Program establishes the procedures and standards necessary for evaluating all USDA Forest Service Cooperative suppression projects. (...) Treatment Monitoring procedures require four stages of data collection: - pre-treatment - aircraft calibration - on-site monitoring (during treatment) - post-treatment Data collected during all four stages is necessary for a spray block to be entered into the Treatment Monitoring Program. (...) If treatment occurs on more than one day, record treatment block data for subsequent days’ treatment.
Language:English
Score: 651325.1 - https://www.fao.org/forestry/6...e1f630a28c2f330649d34ed635.pdf
Data Source: un
ARV treatment guidelines for resource-limited settings a) Objectives of the document The updated treatment guidelines are intended to support and facilitate the more universal access to antiretroviral treatment by proposing a public health approach. The key tenets of this approach are: 1. standardization and simplifi cation of antiretroviral treatment regimens with the objective of ‘universal access’, i.e. that all those who need it will have access to antiretroviral treatment; 2. scaling up of antiretroviral treatment programmes to support the effi cient implementation of long-term therapy programmes in resource-limited settings; 3. ensuring that antiretroviral treatment programmes are based on scientifi c evidence, in order to avoid the use of substandard treatment protocols, which compromise the treatment outcome of individual clients and create the potential for emergence of drug-resistant viruses. b) Description of content The guidelines present options for fi rst- and second-line regimens, and recommend when to start antiretroviral treatment, reasons for changing it, and what regimens to continue if treatment needs to be changed. They also address how treatment should be monitored, with specifi c reference to the side effects of antiretroviral treatment, and make specifi c recommendations for certain patient subgroups.
Language:English
Score: 649783.5 - https://www.who.int/3by5/publi.../briefs/oms09arvguidelines.pdf
Data Source: un
WHO | World Health Organization (WHO) "Preparing for Treatment Programme" Access Home Alt+0 Content Alt+2 Search Menu 3 by 5 home About 3 by 5 Country support Capacity building Partnership AIDS medicines and diagnostics service Documents Media centre World Health Organization (WHO) "Preparing for Treatment Programme" Fact sheet About the "Preparing for Treatment Programme" - Background and aim In the 20 years since the HIV/AIDS epidemic began, people living with HIV or AIDS (PLWHA) have been at the forefront of advocating for access to antiretroviral treatment (ART) and providing care for others living with the virus. (...) What is "Treatment Preparedness"? Treatment Preparedness is the term that refers to a person's readiness to begin antiretroviral treatment. (...) An example of treatment preparedness activities can be taken from South Africa-based organization, the Treatment Action Campaign (TAC) which developed an easy-to-use manual to help people living with HIV/AIDS to follow their treatment regimens effectively.
Language:English
Score: 649674.3 - https://www.who.int/3by5/partners/tpsheet/en/
Data Source: un
WHO | Antiretroviral treatment (ART) guidelines and technical and operational recommendations for ART Access Home Alt+0 Content Alt+2 Search Menu 3 by 5 home About 3 by 5 Country support Capacity building Partnership AIDS medicines and diagnostics service Documents Media centre Antiretroviral treatment (ART) guidelines and technical and operational recommendations for ART Background Scaling up the delivery of ART in resource-poor settings in line with 3 by 5 requires simplified treatment regimes that can be used safely and effectively by a broad range of health professionals. (...) The key tenets of this approach are: 1. standardization and simplification of antiretroviral treatment regimens with the objective of 'universal access', i.e. that all those who need it will have access to antiretroviral treatment; 2. scaling up of antiretroviral treatment programmes to support the efficient implementation of long-term therapy programmes in resource-limited settings; 3. ensuring that antiretroviral treatment programmes are based on scientific evidence, in order to avoid the use of substandard treatment protocols, which compromise the treatment outcome of individual clients and create the potential for emergence of drug-resistant viruses. b) Description of content The guidelines present options for first- and second-line regimens, and recommend when to start antiretroviral treatment, reasons for changing it, and what regimens to continue if treatment needs to be changed. They also address how treatment should be monitored, with specific reference to the side effects of antiretroviral treatment, and make specific recommendations for certain patient subgroups.
Language:English
Score: 649133.45 - https://www.who.int/3by5/publi...ions/briefs/arv_guidelines/en/
Data Source: un
  12
12 The Collaborative Fund for HIV Treatment Preparedness A project of Tides Foundation in partnership with the International Treatment Preparedness Coalition I would like to say that the key to successful treatment education and advocacy is remembering our own dignity as human beings and taking hold of the power of that truth. (...) Paisan Suwannawong Thai AIDS Treatment Action Group, Thailand Speaking at the March 2003 International Treatment Preparedness Summit The Collaborative Fund for HIV Treatment Preparedness is a community-driven funding mechanism to support HIV treatment advocacy and education efforts in Africa, Asia, the Caribbean and Latin America, and Eastern Europe/Central Asia. (...) In July 2004, the WHO announced funding for treatment preparedness activities through its Preparing for Treatment Program.
Language:English
Score: 648732.8 - https://www.who.int/3by5/partners/en/factsheet.pdf
Data Source: un
ILO: Employment crucial for successful HIV/AIDS treatment People living with HIV who are employed are almost 40 per cent more likely to stick to HIV treatment than those without a job, says a new ILO study released ahead of World AIDS Day. News | 27 November 2013 The report – The Impact of Employment on HIV Treatment Adherence – analyses the findings of 23 studies on the relationship between employment and HIV treatment, and covers more than 6,500 people living with HIV. (...) It found that unemployment, particularly in low and middle-income countries, affects people’s ability to afford treatment, which can lead to interruptions, low viral suppression and ultimately treatment failure.
Language:English
Score: 646893.36 - www.ilo.org/moscow/news...WCMS_248759/lang--en/index.htm
Data Source: un
Angola "3 by 5" country profile on treatment scale up, June 2005 pdf, 275kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 176kb Country health indicators 2. Belize "3 by 5" country profile on treatment scale up, June 2005 pdf, 184kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 113kb Country health indicators 3. Botswana "3 by 5" country profile on treatment scale up, June 2005 pdf, 282kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 200kb Country health indicators 4.
Language:English
Score: 646893.36 - https://www.who.int/3by5/countryprofiles/en/
Data Source: un
ILO: Employment crucial for successful HIV/AIDS treatment People living with HIV who are employed are almost 40 per cent more likely to stick to HIV treatment than those without a job, says a new ILO study released ahead of World AIDS Day. News | 27 November 2013 The report – The Impact of Employment on HIV Treatment Adherence – analyses the findings of 23 studies on the relationship between employment and HIV treatment, and covers more than 6,500 people living with HIV. (...) It found that unemployment, particularly in low and middle-income countries, affects people’s ability to afford treatment, which can lead to interruptions, low viral suppression and ultimately treatment failure.
Language:English
Score: 646893.36 - https://www.ilo.org/moscow/new...WCMS_248759/lang--en/index.htm
Data Source: un